The company called Radical Numerics has published details of the project on its website, revealing that they have trialed an AI-engineered viral treatment on a human subject. "If it works, that's incredible.". Market analysts and industry participants are closely tracking the development to assess its impact on consumer pricing, liquidity, and domestic business sentiment over the coming quarters.